Clinical trial

Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure

NCT00527059

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2007-10-01

PhasePHASE4

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2007-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Renal Insufficiencyunresolved

Interventions

Levosimendan in addition to standard therapyDRUG

spironolactone, beta-blockers,eccDRUG

Sponsors & collaborators

University of Roma La Sapienzalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00527059 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.